Antimyosin antibody imaging in experimental aortic regurgitation

Journal of Nuclear Cardiology

Volumn 4, Issue 1, 1997, Pages 25-32

  Lu, Ping ^a   Zanzonico, Pat ^a   Goldfine, Steven M ^a   Hardoff, Ruth ^a   Magid, Norman ^a   Gentile, Raffaele ^a   Herrold, Edmund M ^a   Borer, Jeffrey S ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Antimyosin antibody; Aortic regurgitation; Cardiac imaging; Volume overload

Indexed keywords

MYOSIN ANTIBODY IN 111; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; AORTA VALVE REGURGITATION; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; HEART SCINTISCANNING; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; SCINTILLATION CAMERA;

EID: 0030965434     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(97)90046-5     Document Type: Article

References (39)

1. Maron B, Ferrans V, Roberts W. Ultrastructural features of degenerated cardiac muscle cells in patients with cardiac hypertrophy. Am J Pathol 1975;79:387-413.
2. Maron B, Ferrans V, Roberts W. Myocardial ultrastructure in patients with chronic aortic valve disease. Am J Cardiol 1975;35:725-39.
3. Schwarz F, Flameng W, Schaper J, Henrlein F. Myocardial structure and function in patients with aortic valve disease and their relation to postoperative results. Am J Cardiol 1977;41:661-9.
4. Schwarz F, Flameng W, Schaper J, Henrlein F. Correlation between myocardial structure and diastolic properties of the heart in chronic aortic valve disease: effects of corrective surgery. Am J Cardiol 1978;42:895-903.
5. Fuster V, Danielson M, Robb R, Broadbent J, Brown A, Elveback L. Quantitation of left ventricular myocardial fiber hypertrophy and interstitial tissue in human hearts with chronically increased volume and pressure overload. Circulation 1977;55:504-8.
6. Hess O, Ritter M, Schneider J, Grimm J, Rurina M, Krayenbuebl H. Diastolic stiffness and myocardial structure in aortic valve disease before and after valve replacement. Circulation 1984;69: 855-65.
7. Krayenbuehl H, Hess O, Monrad E, Schneider J, Mall G, Rurina M. Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation 1988;79:744-55.
8. Villari B, Campbell SE, Hess OM, et al. Influence of collagen network on left ventricular systolic and diastolic function in aortic valve disease. J Am Coll Cardiol 1993;22:1477-84.
9. Weber K, Brilla C, Janicki J. Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res 1993;27:341-8.
10. Brilla C, Janicki J, Weber K. Impaired diastolic function and coronary reserve in genetic hypertension. Circ Res 1991;69:107-15.
11. Villari B, Hess O, Kaufmann P, Krogmann O, Grimm J, Krayenbuehl H. Effect of aortic valve stenosis (pressure overload) and regurgitation (volume overload) on left ventricular systolic and diastolic function. Am J Cardiol 1992;69:927-34.
12. Liu SK, Magid NM, et al. Interstitial fibrosis and myocyte injury: relation to heart failure in aortic regurgitation [abstract]. Clin Res 1992;40:273A.
13. Khaw BA, Fallon JT, Strauss HW, Haber E. Myocardial infarct imaging of antibodies to canine cardiac myosin with indium-111-diethylenetriamine pentaacetic acid. Science 1980;209:295-7.
14. Khaw BA, Fallon JT, Beller GA, Haber E. Specificity of the location of myosin specific antibody fragments in experimental myocardial infarction: histologic, histochemical, autoradiographic and scintigraphic studies. Circulation 1979;60:1527-31.
15. Khaw BA, Gold HK, Yasuda T, et al. Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin-specific antibody. Circulation 1986;74:501-8.
16. Berger H, Lahiri A, Leppo J, et al. Antimyosin imaging in patients with ischemic chest pain: Initial results of phase III multicenter trial [abstract]. J Nucl Med 1988;29:805-6.
17. Braat SH, deZwaan C, Teule J, Heidendal G, Wellens HJJ. Value of indium-111 monoclonal antimyosin antibody for imaging in acute myocardial infarction. Am J Cardiol 1987;60:725-6.
18. Johnson LL, Seldin DW, Becker LC, et al. Antimyosin imaging in acute transmural myocardial infarctions: results of a multicenter clinical trial. J Am Coll Cardiol 1989;13:27-35.
19. Volpini M, Giubbini R, Gei P, et al. Diagnosis of acute myocardial infarction by indium-111 antimyosin antibodies and correlation with the traditional techniques for the evaluation of extent and localization. Am J Cardiol 1989;63:7-13.
20. Yasuda T, Palacios IF, Dec W, et al. Indium 111-monoclonal antimyosin antibody imaging in the diagnosis of acute myocarditis. Circulation 1987;76:306-11.
21. Dec GW, Palacios I, Yasuda T, et al. Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. J Am Coll Cardiol 1990;16:97-104.
22. Carrio I, Berna L, Ballester M, et al. Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection. J Nucl Med 1988;29:1893-900.
23. Narula J, Khaw BA, Dec W Jr, et al. Recognition of acute myocarditis masquerading as acute myocardial infarction. N Engl J Med 1993;328:100-4.
24. Yamada T, Matsumori A, Watanabe Y, et al. Pharmacokinetics of indium-111-labeled antimyosin monoclonal antibody in murine experimental viral myocarditis. J Am Coll Cardiol 1990;16:1280-6.
25. Kishimoto C, Hung GL, Ishibashi M, et al. Natural evolution of cardiac function, cardiac pathology and antimyosin scan in a murine myocarditis model. J Am Coll Cardiol 1991;17:821-7.
26. Obrador D, Ballester M, Carrio I, Berna L, Pons-Llado G. High prevalence of myocardial monoclonal antimyosin antibody uptake in patients with chronic idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1989;13:1289-93.
27. Obrador D, Ballester M, Carrio I, et al. Active myocardial damage without attending inflammatory response in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1993;21:1667-71.
28. Obrador D, Ballester M, Carrio I, et al. Presence, evolving changes, and prognostic implications of myocardial damage detected in idiopathic and alcoholic dilated cardiomyopathy by indium-111 monoclonal antimyosin antibodies. Circulation 1994;89:2054-61.
29. Nishimura T, Nagata S, Uehara T, Hayashida K, Mitani I, Kumita SI. Assessment of myocardial damage in dilated-phase hypertrophic cardiomyopathy by using indium-III antimyosin Fab myocardial scintigraphy. J Nucl Med 1991;32:1333-7.
30. Nakata T, Gotoh M, Yonekura S, et al. Myocardial accumulation of monoclonal antimyosin Fab in hypertrophic cardiomyopathy and postpartum cardiomyopathy. J Nucl Med 1991;32:2291-4.
31. Ballester-Rodes M, Carrio-Gasset I, Abadal-Berini L, Obrador-Mayol D, Berna-Roqueta L, Caralps-Riera JM. Patterns of evolution of myocyte damage after human heart transplantation detected by indium-111 monoclonal antimyosin. Am J Cardiol 1988;62:623-7.
32. Magid NM, Opio G, Wallerson DC, Young MS, Borer JS. Heart failure due to chronic experimental aortic regurgitation. Am J Physiol 1994;267:H556-62.
33. Magid NM, Wallerson DC, Borer JS, et al. Left ventricular diastolic and systolic performance during long-term follow-up of experimental aortic regurgitation. Am J Physiol 1992;263:H226-33.
34. Magid NM, Young MS, Wallerson DC, et al. Hypertrophic and functional response to experimental chronic aortic regurgitation. J Mol Cell Cardiol 1988;20:239-46.
35. Young MS, Magid NM, Wallerson DC, et al. Echocardiographic left ventricular mass measurement in small animals: anatomic validation in normal and aortic regurgitant rabbits. Am J Noninvasive Cardiol 1990;4:145-53.
36. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predetermined specificity. Nature 1975;256:495-7.
37. Khaw BA, Scott J, Fallon JT, Cahill SL, Haber E, Homey C. Myocardial injury: quantitation by cell sorting initiated with antimyosin fluorescent spheres. Science 1982;217:1050-3.
38. Khaw BA, Beller GA, Haber E, Smith TW. Localization of cardiac myosin-specific antibody in myocardial infarction. J Clin Invest 1976;58:439-46.
39. 2 fragments. Circulation 1978;58:1137-42.